Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation

Glenn M Chertow1, Ricardo Correa-Rotter2, Kai-Uwe Eckardt3

  • 1Stanford University School of Medicine, Stanford Palo Alto, CA 94305, USA.

Eclinicalmedicine
|July 16, 2024
PubMed

Insights

Chronic kidney disease (CKD) is rising globally, with projections showing 436.6 million cases by 2027. Early screening and policy interventions are crucial for managing this growing burden and its complications.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a significant global health issue, exacerbated by type 2 diabetes, hypertension, and an aging population.
  • The 'Inside CKD' initiative aims to increase awareness of the substantial burden posed by CKD worldwide.

Purpose of the Study:

  • To estimate the clinical burden of CKD from 2022 to 2027 using a peer-reviewed microsimulation model.
  • To project the prevalence of CKD, kidney replacement therapy, cardiovascular complications, comorbidities, and mortality in affected populations.

Main Methods:

  • A microsimulation method was employed, utilizing demographic data from the Americas, Europe, and Asia-Pacific/Middle East.
  • Virtual populations were generated to project CKD-related health outcomes over a five-year period.

Main Results:

  • CKD prevalence is projected to reach 436.6 million cases by 2027, a 5.8% increase from 2022, with approximately 80% remaining undiagnosed.
  • By 2027, CKD patients are projected to experience high rates of heart failure (8859/100,000), myocardial infarction (10,244/100,000), and stroke (7797/100,000).

Conclusions:

  • The clinical impact of CKD is substantial and expected to grow, highlighting the need for improved management strategies.
  • Health policy interventions focusing on screening, early diagnosis, and effective treatments are essential to mitigate the increasing burden of CKD and its complications.
Abstract